Last reviewed · How we verify

NCT04502940

Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?

Completed Last updated 3 May 2021
What this trial tests

trial testing Flow Cytometric analysis in Pancreatitis in 53 participants. Completed in 29 April 2021.

Timeline
1 June 2020
Primary endpoint
1 April 2021
29 April 2021

Quick facts

Lead sponsorIstanbul Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment53
Start date1 June 2020
Primary completion1 April 2021
Estimated completion29 April 2021
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Training and Research Hospital

Who can join

Adults 18 to 80, any sex, with Pancreatitis or Lymphocytic Infiltrate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pancreatitis is a common complication especially in patients with gallbladder stones, most patients with biliary pancreatitis may recover spontaneously without sequelae, but in 10-20% of patients, the disease is severe and mortality rates of up to 30% are detected in these patients. In the evaluation of acute biliary pancreatitis, many scoring systems have been established (Atlanta, Ranson, APACHE, BISAP etc.) from past to present to determine morbidity and mortality of the disease. In this study, the investigators aimed to evaluate the correlation between morbidity and mortality of acute biliary pancreatitis and lymphocyte subtypes with Flow-cytometry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Flow Cytometric analysis

Trials testing the same drug.

Other recruiting trials for Pancreatitis

Currently open trials in the same condition.

Other Istanbul Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04502940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing